Beranda600664 • SHA
add
Harbin Pharmaceutical Group Co., Ltd.
Tutup sebelumnya
¥3,64
Rentang tahun
¥2,41 - ¥4,13
Kapitalisasi pasar
9,49 M CNY
Volume Rata-Rata
35,52 jt
Rasio P/E
16,19
Hasil dividen
-
Bursa utama
SHA
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CNY) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 4,00 M | 6,05% |
Biaya operasional | 977,13 jt | 23,80% |
Laba bersih | 166,64 jt | 175,81% |
Margin laba bersih | 4,17 | 160,62% |
Penghasilan per saham | — | — |
EBITDA | 274,38 jt | 50,36% |
Tarif pajak efektif | 22,99% | — |
Neraca
Total aset
Total liabilitas
| (CNY) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 3,18 M | 22,51% |
Total aset | 14,24 M | 3,68% |
Total liabilitas | 8,48 M | -0,98% |
Total ekuitas | 5,76 M | — |
Saham yang beredar | 2,52 M | — |
Harga terhadap nilai buku | 1,82 | — |
Tingkat pengembalian aset | 3,80% | — |
Tingkat pengembalian modal | 7,00% | — |
Arus Kas
Perubahan kas bersih
| (CNY) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 166,64 jt | 175,81% |
Kas dari operasi | 344,42 jt | -1,27% |
Kas dari investasi | -15,62 jt | -70,10% |
Kas dari pembiayaan | 15,19 jt | 115,53% |
Perubahan kas bersih | 344,23 jt | 40,80% |
Arus kas bebas | 377,94 jt | 6,99% |
Tentang
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Didirikan
1988
Situs
Karyawan
9.853
